[Leukotriene receptor antagonists--possible therapeutic option in the treatment of atopic dermatitis ].
Cysteinyl leukotrienes have been shown to be important in the pathogenesis of such atopic disorders as asthma and allergic rhinoconjunctivitis. Therefore, leukotriene receptor antagonists are expected to be effective in the treatment of these diseases. Also in the case of patients with atopic dermatitis attempts have been made at administration of leukotriene receptor antagonists and this article reviews current data on the experimental evidence and clinical efficacy of this type of treatment of atopic dermatitis.
Czarnecka-Operacz
Magdalena
M
Ośrodek Diagnostyki Chorób Alergicznych, Akademii Medycznej w Poznaniu.
Jenerowicz
Dorota
D
D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D020024:Leukotriene Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D015289:Leukotrienes / Q000378:metabolism; D008407:Mast Cells / Q000276:immunology / Q000378:metabolism; D014581:Urticaria / Q000276:immunology / Q000503:physiopathology
D020024:Leukotriene Antagonists; D015289:Leukotrienes
Leki antyleukotrienowe--mozliwości zastosowania w terapii atopowego zapalenia skóry.